Merck KGaA | Cash Flow

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,209
1,165
1,124
1,633
2,610
3,396
Depreciation, Depletion & Amortization
1,238
1,262
1,383
1,806
1,759
1,748
Other Funds
37
3
4
3
4
2,659
Funds from Operations
2,461
2,535
2,625
3,130
4,020
2,485
Changes in Working Capital
236
170
430
612
1,324
266
Net Operating Cash Flow
2,226
2,706
2,195
2,518
2,696
2,219
Capital Expenditures
517
624
693
848
1,311
Sale of Fixed Assets & Businesses
298
35
95
26
55
Purchase/Sale of Investments
641
365
2,117
113
34
Net Investing Cash Flow
875
1,993
11,936
503
1,147
Cash Dividends Paid - Total
414
506
564
597
621
Issuance/Reduction of Debt, Net
621
1,620
7,732
1,308
1,245
Net Financing Cash Flow
1,073
1,112
7,164
1,908
1,870
Net Change in Cash
251
1,898
2,046
115
351
Free Cash Flow
1,819
2,225
1,681
1,802
1,777
Net Assets from Acquisitions
15
1,771
13,482
156
17
Other Sources
-
2
27
365
160
Exchange Rate Effect
27
73
531
8
30
Other Uses
-
-
-
3
-

About Merck KGaA

View Profile
Address
Frankfurter Strasse 250
Darmstadt Hessen 64293
Germany
Employees -
Website http://www.emdgroup.com
Updated 07/08/2019
Merck KGaA engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and manufactures prescription medicines used to treat cancer, multiple sclerosis, and infertility.